Fatty acid esters as bioactive compounds
AssigneeScotia Holdings PLC
InventorsDavid Frederick Horrobin, Mehar Manku, Austin McMordie, Philip Knowles, Peter Redden, Andrea Pitt
Life of this patent
Estimating the term…
Abstract
Compounds of structure (I), and when for use in therapy: where R1 is an acyl group derived from a C16-30 fatty acid with two or more cis or trans double bonds and particularly an n-6 or n-3 series EFA or conjugated linoleic acid, or columbinic acid, or parinaric acid and R2 is as R1 the same or different, or any other nutrient, drug or other bioactive residue released as the active in the body and R3 is either hydrogen, fully hydrocarbon, or containing heteroatoms, preferably an alkyl group particularly a C1-C4 alkyl group.
Claims64
A compound having the following structure
- where R1 is an acyl group derived from a C16-30 fatty acid with two or more cis or trans double bonds and R2 is a nutrient, drug or other bioactive residue as the active in the body and R3 is either hydrogen of gydrocarbyl, with the proviso that R2 is not the residue of nicotinic acid.
Dependencies are inferred from the claim text.